Found: 16
Select item for more details and to access through your institution.
Kymriah Received Accelerated FDA Approval for Relapsed or Refractory Follicular Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 24
- Publication type:
- Article
Enhertu Received Regular FDA Approval for Patients with Unresectable or Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 25
- Publication type:
- Article
Vidaza Received New Indication for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 25
- Publication type:
- Article
Tibsovo Received a New Indication, in Combination with Onureg, for Newly Diagnosed Patients with AML and IDH1 Mutation.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 24
- Publication type:
- Article
Yescarta First CAR T-Cell Therapy FDA Approved for Large B-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 26
- Publication type:
- Article
Biden May Stop His Cancer Moonshot's Launch.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 22
- By:
- Publication type:
- Article
Fertility Preservation in Patients with Cancer: How Navigators Can Get the Ball Rolling.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 20
- Publication type:
- Article
AAM Calls for Federal Trade Commission to Investigate PBM Business Practices.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 16
- By:
- Publication type:
- Article
Neoadjuvant Chemoimmunotherapy May Become New Standard of Care for Patients with Resectable NSCLC.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 18
- By:
- Publication type:
- Article
Adding Ibrutinib to Chemoimmunotherapy Improves PFS in Older Patients with Newly Diagnosed Mantle-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 11
- By:
- Publication type:
- Article
Acalabrutinib Shows Promise in Patients with Marginal Zone Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 10
- By:
- Publication type:
- Article
Dostarlimab Demonstrates 100% Complete Response Rate in Subset of Patients with dMMR Rectal Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 8
- By:
- Publication type:
- Article
Genmab: Scaling with Purpose, Precision, and Agility to Serve Patients, Physicians, and Payers.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 2
- Publication type:
- Article
Niraparib plus Abiraterone Combination Extends PFS in Men with CRPC and HRR Gene Mutations.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 1
- By:
- Publication type:
- Article
ASCO President Stresses the Importance of Innovation for Advancing Equitable Cancer Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 1
- By:
- Publication type:
- Article
Refueling When Your Emotional Tank Is Empty: Addressing Healthcare Worker Burnout.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 1
- By:
- Publication type:
- Article